Table 1 Patient characteristics
Total enrolled: 40 | N | % |
|---|---|---|
Sex | ||
Male | 33 | 82.5 |
Female | 7 | 17.5 |
Age (year) | ||
Median | 74 | |
Range | 70–88 | |
Stage | ||
IIIB | 11 | 27.5 |
IV | 29 | 72.5 |
Histology | ||
Squamous cell carcinoma | 14 | 35 |
Adenocarcinoma | 18 | 45 |
Bronchiolar–alveolar carcinoma | 4 | 10 |
Undifferentiated NSCLC | 4 | 10 |
Site of metastases | ||
Lung | 23 | |
Liver | 3 | |
Bone | 7 | |
Brain | 2 | |
Pleura | 4 | |
Adrenal | 2 | |
Skin | 2 | |
Number of metastatic sites | ||
0 | 11 | 27.5 |
1 | 19 | 47.5 |
2 | 6 | 15 |
3+ | 4 | 10 |
ECOG performance status | ||
0 | 10 | 25 |
1 | 27 | 67.5 |
2 | 3 | 7.5 |
Symptoms at study entry | 20 | 50 |
Previous chemotherapy lines | ||
1 | 21 | 52.5 |
2 | 16 | 40 |
3+ | 3 | 7.5 |
Pretreated with platinum | 19 | 47.5 |
